Cargando…

Altered expression of the CSMD1 gene in the peripheral blood of schizophrenia patients

BACKGROUND: Schizophrenia (SCZ) is a heritable, refractory, and devastating psychiatric disorder. Previous studies have shown that the variants of CUB and sushi multiple domains 1 (CSMD1) demonstrate significant genome-wide association with SCZ. However, few studies have been conducted on the effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yansong, Fu, Xiaoqian, Tang, Zhen, Li, Cui, Xu, Yong, Zhang, Fuquan, Zhou, Deyi, Zhu, Chunming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466712/ https://www.ncbi.nlm.nih.gov/pubmed/30987620 http://dx.doi.org/10.1186/s12888-019-2089-4

Ejemplares similares

Altered expression of the DISC1 gene in peripheral blood of patients with schizophrenia
por: Fu, Xiaoqian, et al.
Publicado: (2020)

No association between the rs10503253 polymorphism in the CSMD1 gene and schizophrenia in a Han Chinese population
por: Liu, Yansong, et al.
Publicado: (2016)

Neuropsychological Deficits in Mice Depleted of the Schizophrenia Susceptibility Gene CSMD1
por: Steen, Vidar M., et al.
Publicado: (2013)

Assessment of Behaviors Modeling Aspects of Schizophrenia in Csmd1 Mutant Mice
por: Distler, Margaret G., et al.
Publicado: (2012)

Deregulatory miRNA-BDNF Network Inferred from Dynamic Expression Changes in Schizophrenia
por: Fu, Xiaoqian, et al.
Publicado: (2022)

Gene expression profiling in peripheral blood mononuclear cells of early-onset schizophrenia
por: Sun, Li, et al.
Publicado: (2015)

Loss of CSMD1 disrupts mammary epithelial morphogenesis
por: Kamal, M, et al.
Publicado: (2010)

The Role of Csmd1 during Mammary Gland Development
por: Burgess, Samuel J., et al.
Publicado: (2021)

Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability
por: Hatzimanolis, Alex, et al.
Publicado: (2022)

Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models
por: Drgonova, Jana, et al.
Publicado: (2015)

Altered Expression of Glucocorticoid Receptor and Neuron-Specific Enolase mRNA in Peripheral Blood in First-Episode Schizophrenia and Chronic Schizophrenia
por: Liu, Yong, et al.
Publicado: (2020)

Altered expression of mRNA profiles in blood of early-onset schizophrenia
por: Xu, Yong, et al.
Publicado: (2016)

Genome-wide mRNA expression analysis of peripheral blood from patients with obsessive-compulsive disorder
por: Song, Yuqing, et al.
Publicado: (2018)

Genetic Variants in CSMD1 Gene Are Associated with Cognitive Performance in Normal Elderly Population
por: Stepanov, Vadim, et al.
Publicado: (2017)

Rare mutations in the complement regulatory gene CSMD1 are associated with male and female infertility
por: Lee, Arthur S., et al.
Publicado: (2019)

Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
por: Escudero-Esparza, Astrid, et al.
Publicado: (2016)

Whole-exome sequencing associates novel CSMD1 gene mutations with familial Parkinson disease
por: Ruiz-Martínez, Javier, et al.
Publicado: (2017)

CSMD1 Shows Complex Patterns of Somatic Copy Number Alterations and Expressions of mRNAs and Target Micro RNAs in Esophageal Squamous Cell Carcinoma
por: Hu, Nan, et al.
Publicado: (2022)

LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling
por: Liu, Ji, et al.
Publicado: (2020)

Exploring the mRNA expression level of RELN in peripheral blood of schizophrenia patients before and after antipsychotic treatment
por: Yin, Jiajun, et al.
Publicado: (2020)

Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines
por: Richter, Toni M, et al.
Publicado: (2005)

CSMD3 is Associated with Tumor Mutation Burden and Immune Infiltration in Ovarian Cancer Patients
por: Lu, Nan, et al.
Publicado: (2021)

Association of CSMD1 with Tumor Mutation Burden and Other Clinical Outcomes in Gastric Cancer
por: Wang, Xuning, et al.
Publicado: (2021)

The Diverse Role of CUB and Sushi Multiple Domains 1 (CSMD1) in Human Diseases
por: Ermis Akyuz, Esra, et al.
Publicado: (2022)

Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
por: Escudero-Esparza, Astrid, et al.
Publicado: (2023)

Csmd2 Is a Synaptic Transmembrane Protein that Interacts with PSD-95 and Is Required for Neuronal Maturation
por: Gutierrez, Mark A., et al.
Publicado: (2019)

Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker
por: Zhang, Huiyun, et al.
Publicado: (2022)

BDNF Gene's Role in Schizophrenia: From Risk Allele to Methylation Implications
por: Fu, Xiaoqian, et al.
Publicado: (2020)

Combined identification of ARID1A, CSMD1, and SENP3 as effective prognostic biomarkers for hepatocellular carcinoma
por: Zhao, Yuanyuan, et al.
Publicado: (2021)

Genome-Wide Supported Risk Variants in MIR137, CACNA1C, CSMD1, DRD2, and GRM3 Contribute to Schizophrenia Susceptibility in Pakistani Population
por: Fatima, Ambrin, et al.
Publicado: (2017)

Peripheral Blood-Based Gene Expression Studies in Schizophrenia: A Systematic Review
por: Wagh, Vipul Vilas, et al.
Publicado: (2021)

Up-regulated expression of oxytocin mRNA in peripheral blood lymphocytes from first-episode schizophrenia patients
por: Yang, Xiudeng, et al.
Publicado: (2017)

miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1)
por: Zhu, Qiao, et al.
Publicado: (2016)

Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation
por: Terzic, Julie, et al.
Publicado: (2020)

CSMD1 Mutations Are Associated with Increased Mutational Burden, Favorable Prognosis, and Anti-Tumor Immunity in Gastric Cancer
por: Huang, Taobi, et al.
Publicado: (2021)

MicroRNA Expression Aberration as Potential Peripheral Blood Biomarkers for Schizophrenia
por: Lai, Chi-Yu, et al.
Publicado: (2011)

NADPH-oxidase 4 gene over-expression in peripheral blood lymphocytes of the schizophrenia patients
por: Ershova, Elizaveta S., et al.
Publicado: (2022)

Altered Gene Expression in Schizophrenia: Findings from Transcriptional Signatures in Fibroblasts and Blood
por: Cattane, Nadia, et al.
Publicado: (2015)

CSMD1 Mutation Related to Immunity Can Be Used as a Marker to Evaluate the Clinical Therapeutic Effect and Prognosis of Patients with Esophageal Cancer
por: Fan, Xin, et al.
Publicado: (2021)

New Insight into the human genetic diversity in North African populations by genotyping of SNPs in DRD3 , CSMD1 and NRG1 genes
por: Mestiri, Souhir, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f49cm8krmp70rt3n90no7gplbq